Farrugia says the healthcare innovation cycle used to be about 17 years and has shortened to about 12 years.
“The healthcare innovation cycle, we all know, used to be around 17 years. It's now down to around 12. It's still long.”

3 Sep 2024 · 21m · Gianrico Farrugia, Paul Laudicina · 21 quoted facts
Mayo Clinic CEO Dr. Gianrico Farrugia argues that healthcare has reached an inflection point. The traditional 'pipeline' model of care can no longer scale, so the industry must shift to a shared 'platform' model, and it must adopt AI quickly rather than wait for perfect regulation. Doing so can spread better, cheaper care globally.
The tension is between remarkable scientific progress and a system straining to deliver it. New cures, home-based care and AI are arriving, yet workforce shortages, rising costs and expensive technology mean fewer organizations may be able to deliver the best care. Farrugia says platforms, regulation, faster training and shared tools can narrow that widening gap.
Farrugia says the problem is not money, talent or bureaucracy but an architecture built over hundreds of years. Mayo's response is a platform others can build on, and he says systems on three continents have joined and seen better outcomes, lower cost and higher satisfaction.
An EKG algorithm that helps diagnose heart failure was built into Mayo's record, then reused by nurses in Nigeria on phones and adapted for children in Peru and Pakistan. Because the platform exists, nobody has to reinvent the tool each time.
Over three years Mayo found it can treat patients at home at 80% of the cost of an admission, with 50% fewer readmissions than comparable hospital patients. It works only because a platform supplies backup like reliable Wi-Fi, laundry help and medication delivery.
Farrugia argues healthcare is so imperfect that AI's potential to reduce long-standing biases is too great to delay. He says regulation is still needed, because conservative institutions won't move without it, and notes that trust in AI is very low.
Farrugia cites a projected 10 million healthcare worker shortage by 2030, rising violence against staff and narrower wage gaps with other fields. Mayo is responding with faster AI-assisted training and clear career ladders, cutting MR technician training from 18 months to eight.
Farrugia says a pipeline is the traditional model where each organization builds and delivers care on its own, which can't scale. A platform is shared infrastructure that Mayo and others can use to build, customize and spread tools and services widely.
Farrugia says no. He says algorithms plus physicians give better care than either alone, and that hospitals will not disappear but must be redesigned to blend digital and physical care.
Farrugia says Mayo runs 159 AI algorithms in daily practice. One example is an algorithm that lets a nurse use a single smartwatch EKG strip to detect possible heart failure.
Farrugia says Mayo's early results show home IV chemotherapy is at least equivalent to an infusion center on safety. Its advanced care at home program costs about 80% of a hospital admission and has 50% fewer readmissions.
Farrugia says the work is hard, disrespect and violence toward staff has grown, and wage gaps with other fields have narrowed. Mayo is shortening training using AI and virtual education and giving staff a clear career path from day one.
Stated by the speakers. Each quote matches the transcript, which shows what was said, not that it is true.
Farrugia says the healthcare innovation cycle used to be about 17 years and has shortened to about 12 years.
“The healthcare innovation cycle, we all know, used to be around 17 years. It's now down to around 12. It's still long.”
Farrugia says that when Mayo Clinic made its strategic decision about five years earlier, Newsweek had already ranked it the number one hospital in the world.
“Newsweek had already proclaimed us to be number one hospital in the world.”
Mayo Clinic created a strategic plan called Bold. Forward (transcribed 'BOW Forward') with three objectives, including creating more cures for acute and chronic diseases.
“So we created a strategic plan called BOW Forward, three intertwining objectives, create more cures for both acute and chronic diseases”
Farrugia says hospital systems across three continents have joined Mayo Clinic's platform effort.
“hospital systems have joined us across three continents.”
Farrugia cites a World Health Organization estimate of a 10 million healthcare worker shortage by 2030.
“WHO estimates, as you said, 10 million healthcare worker shortage by 2030.”
Farrugia says Mayo Clinic found a single smartwatch EKG strip, with an algorithm, lets a nurse diagnose possible heart failure 34% better than a cardiologist.
“we found that we can use now a single EKG strip from any smartwatch and have a nurse diagnose the possibility of heart failure 34 % better than a cardiologist.”
The Mayo Clinic EKG algorithm is used by nurses in Nigeria on phones to diagnose heart failure in women about to give birth.
“So in Nigeria, it's now being used by nurses on their phones to diagnose heart failure in women when they're about to give birth.”
Farrugia says the algorithm has been adopted in Peru and Pakistan to detect heart issues in young children.
“In Peru and in Pakistan, it was taken, and now it's being used to detect issues with young kids.”
Farrugia says Mayo Clinic runs 159 AI algorithms in its daily practice.
“Mayo Clinic has 159 AI algorithms that run the practice every day.”
Mayo Clinic launched Cancer Care Beyond Walls, which delivers intravenous chemotherapy at home, in the year before the 2024 retreat.
“Last year, you launched the Cancer Care Beyond Walls, which administers intravenous chemotherapy at home rather than requiring hospitalization.”
Farrugia says early results show Cancer Care Beyond Walls home infusion is at least as safe as an infusion center.
“we've shown that it is at least equivalent to being an infusion center from a safety standpoint.”
Farrugia says Mayo's advanced care at home costs 80% of a hospital admission and cuts readmission rates by 50% versus comparable hospital patients, based on three years of experience.
“over the last three years we found that we can do that at 80 % of the cost of a hospital admission, a 50 % reduction in readmission rates”
Farrugia says Mayo Clinic has an agreement with drone companies to deliver medications to patients at home.
“So we have an agreement with our drone companies to be able to do that.”
Farrugia says Mayo Clinic is investing about $7 billion in facilities and expects to add about $2 billion in Arizona to redesign hospital infrastructure.
“We're at 7 billion at the moment. We'll probably put another 2 billion soon in Arizona to completely reimagine how you do this infrastructure.”
Mayo Clinic created a product called Validate that lets outside developers test their own algorithms on Mayo's platform.
“we created a product called validate and validate allows anybody to get their own algorithm put it onto our platform and then figure out how it performs”
Farrugia says a company's epilepsy algorithm showed weaker performance in one population group when tested on Mayo's Validate, was corrected, and then went on to gain FDA approval.
“a company that had an epilepsy algorithm performed really great but there was one section of the population where it didn't do as well and they were able to go back change that and get fda”
Farrugia says Mayo Clinic plans to bring carbon ion therapy to North America for the first time, pushing hard in 2026.
“We will push hard in 2026 to bring to North America for the first time carbon therapy.”
Farrugia says 11% of all cancers are radio resistant, including some sarcomas that affect children.
“11 % of all cancers are radio resistant, including some of the sarcomas that affect kids.”
Laudicina says Mayo Clinic has about 80,000 employees and is expanding rapidly.
“you've got 80,000 employees and you're expanding pretty uh dramatically”
Farrugia says Mayo Clinic cut the training time for an MR technician from 18 months to eight months using AI and virtual education.
“It used to take us 18 months to train an MR technician using AI, using virtual education.”
Kearney's Global Business Policy Council hosts an annual CEO retreat that has run since 1992; the 2024 event was held in late June in Big Sky, Montana.
“In late June, the Council hosted our annual CEO retreat, an event that has brought together innovative thinkers and leaders worldwide since 1992.”
Farrugia explains why the next few years are pivotal and why the pipeline model has hit its limits, introducing Mayo's platform strategy.
“the architecture in which healthcare has been built over hundreds of years has reached a point where it can no longer scale”
A smartwatch EKG algorithm shows how a platform lets one tool reach Nigeria, Peru and Pakistan, while costs remain a hard societal choice.
“Because the architecture, the platform is available, so you're not having to reinvent every time.”
Farrugia argues healthcare must adopt AI now, help shape regulation and rebuild trust, citing Mayo's 159 algorithms.
“Mayo Clinic has 159 AI algorithms that run the practice every day.”
Mayo's at-home cancer infusion and hospital-at-home programs show cost and readmission benefits, and Farrugia explains why hospitals will remain but be redesigned.
“we found that we can do that at 80 %”
Farrugia outlines plans to invest in platforms, end-to-end AI, the Validate product and carbon therapy for radio-resistant cancers.
“We will push hard in 2026 to bring to North America for the first time carbon therapy.”
Farrugia describes why healthcare is less attractive to workers and how faster training and career ladders may help.
“It used to take us 18 months to train an MR technician using AI, using virtual education.”
Healthcare needs to run towards AI. Not walk towards AI. Healthcare needs to run towards AI. Very soon we'll be doing things that were just simply impossible to do in healthcare. And we need to plan for that and we need to build the infrastructure to be able to do that.
I am Paul Lodacina, Chairman Emeritus of Kearney and founder of its Global Business Policy Council, and this is Reimagining the Future. In late June, the Council hosted our annual CEO retreat, an event that has brought together innovative thinkers and leaders worldwide since 1992. I'm pleased to share on this podcast just the sampling of the fascinating conversations we had as a group convening in Big Sky, Montana. In this episode, I'd like to share an abridged version of my conversation with Dr.
Gianrico Farrugia, who we've been lucky enough to feature on this podcast twice before. Dr. Ferruccia is president and CEO of Mayo Clinic and is truly leading the way forward in profound healthcare innovation. As you'll hear from Dr. Farrugia, five years ago, Mayo Clinic embarked on an ambitious plan to transform its health care system from a pipeline to a platform, starting with Mayo Clinic. That has already yielded extraordinary results, and we discussed his focus on improving the quality of care for all patients, the results of fascinating innovation experiments at Mayo Clinic, and his reflections on the past few years that are relevant for leaders in any industry trying to build partnerships and scale meaningful change.
Dr. Farugia has generously agreed to allow us to share this excerpted conversation. Let's listen in. What's happening now, not just in Mayo, but broadly in healthcare, and where do you see us heading over the next five or ten years?
The next two or three years, less than five probably, you as individuals, you as leaders of organizations, and those of you who either influence or create public policy are going to be making some pretty significant decisions for yourselves and for the companies you run. It's also really clear that there is a lot happening that is at the sea, whatever you want to call it, the inflection point. And the roots of that are probably around 10, 15 years ago.
The healthcare innovation cycle, we all know, used to be around 17 years. It's now down to around 12. It's still long. So we have a pretty good idea what's coming next. But even today, what's happened that is pretty remarkable is that there's a new platform architecture on which a lot of these discoveries are coming from. So new treatments for hypertension, obesity, hypercholesterolemia, Alzheimer's disease, some of the genetic diseases you mentioned a couple, that really aren't sequential.
They're different. And when we look at what's coming next, what we see is some pretty remarkable things that are coming that will change acute diseases and importantly change chronic diseases into cures for chronic diseases. So we're very interested in the spaces, including agents that can diagnose and treat at the same time. That's a field called terranostics. We see coming ahead some of the genetic treatments, and we can talk about cost. But combination therapies are going to become standard, especially in cancer, where you mentioned vaccines.
But it does seem like massive advances are going to happen when you combine a personalized vaccine with immune therapy. So that's all good. Now, in healthcare, there always is a but. And the but for healthcare is that the number of organizations that are going to be able to deliver what patients and people need is going to be less and not more. Every country has the best in healthcare and sort of the worst in healthcare. In the United States, that gap tends to be quite large.
In some countries, it's small, but there always is a gap. We've dealt with it. It's not a good thing, but we've known about it. What's worrisome now is that not the mean, but the median, the difference between the median of healthcare in any individual country and what it can be has grown. And there's no evidence that that is going to shrink. So it's really why five years ago we made the decision at that point Newsweek had already proclaimed us to be number one hospital in the world.
We said, you know, being number one in healthcare is not good enough. And that we strongly feel that the problem is not there aren't any smart people, there's not enough money, governments are too bureaucratic, pharma companies trying to make too much money. It's none of that. It's that the architecture in which healthcare has been built over hundreds of years has reached a point where it can no longer scale. And for scalability to happen, we need to switch the architecture of healthcare from the traditional pipeline model to a platform model.
So we created a strategic plan called BOW Forward, three intertwining objectives, create more cures for both acute and chronic diseases, bring people and data together to create new knowledge that is scalable. And perhaps the one that we talk most about is create the first true platform for healthcare that allows we and others to innovate at scale and at a diffusibility that we couldn't do before. And looking back now, hospital systems have joined us across three continents.
We have several systems in the United States. And we're seeing for the first time that indeed what was thought to be very unlikely, better outcomes, lower cost, greater patient satisfaction can happen if you work on a different architecture than the one that we used to work with.
So that's great, Gianrico, to know that Mayo is doing that and the innovation is clear. But we also see that the sector is struggling with cost structure and labor burdens that are not sustainable. And we see consolidation into larger corporations or many closing entirely. Charlie, all of this obviously impacts patient care and healthcare generally. So which way are things trending? We know and are pleased to hear how it's trending at Mayo, but what about more broadly?
First of all, when I speak, I am making a deliberate effort to speak not about the U.S., about the global healthcare. And it doesn't really matter if it's private, if it's public, or it's hybrid. Same issues are here and will come. WHO estimates, as you said, 10 million healthcare worker shortage by 2030. You all, I am absolutely certain without knowing that you all or a relative of yours had a less than perfect experience in healthcare in the last year.
And because of the things you've mentioned, many hospitals are now struggling to deliver on the basics of healthcare. Now, I want to just explain that a little more. It's not that they're struggling to deliver on the basics of healthcare of 10 years ago. It's just that now the expectation for infant mortality, for maternal mortality, for how you deal with chronic diseases has taken a step up. So it's not like you can actually legislate to go back to the past.
You actually have to legislate to go to the future because our expectations, our baseline has shifted. Again, for me, it's all about making sure that you create environments where innovation can happen and you don't create solutions that are geared to work in one particular place. So to give you an example of what we're trying to do, in healthcare, we have over a period of several years, we found that we can use now a single EKG strip from any smartwatch and have a nurse diagnose the possibility of heart failure 34 % better than a cardiologist.
And a cardiologist, the algorithm can of course diagnose better than the cardiologist without the algorithm. So we did that. It's now part of our Mayo Clinic record and it's there available for everybody. But then we made it available. So in Nigeria, it's now being used by nurses on their phones to diagnose heart failure in women when they're about to give birth. In Peru and in Pakistan, it was taken, and now it's being used to detect issues with young kids.
Because the architecture, the platform is available, so you're not having to reinvent every time. You can take something, customize it, and then make it available. And if you do that, then all the things you just spoke about, the healthcare shortage, well, you can change that. Unevenness in delivery, you can change that. Costs, well, that's a tough one. The reason it's a tough one is because you can lower costs. And we've shown that you can lower costs.
But the technology that is coming is very expensive. And we as society is going to have to make those decisions. But it's not like there is somebody out there that is sort of pulling strings and saying, it's going to be, you know, you can make it happen. There's very expensive technology that is incredibly powerful. And we're going to have to figure out how to put it into our systems, diffuse it, and bring the cost down. But before you do that, we collectively are going to have to figure out some very difficult decisions when it comes to access to the very, very top of what's going to
be available. So, Gianrico, yesterday we talked about AI innovations already having an impact on healthcare at all levels, and particularly for places like the Mayo Clinic, but we all know that the medical system is often resistant to change. Is there a tipping point of AI being used as a routine part of care in the doctor's office, and what's that process of integrating AI technologies into health systems look like?
I'll just say, I was one of the first in healthcare to say that, and what I actually said was the following. Healthcare needs to run towards AI. Not walk towards AI. Healthcare needs to run towards AI. The reason I said that many years ago was that if healthcare were perfect, we could wait until regulations are all set. We could wait until we dive the bias or algorithms. But healthcare's so far from perfect. And the potential for AI to deal with some biases that have plagued healthcare for too long is too great to ignore.
And therefore, healthcare institutions have a responsibility to step up and be not only introducing AI into their own systems, but also play an important role in creating the regulations. And so, for example, I happen to co-chair the National Academy of Medicine, Code of Conduct for AI, we set up CHI, which is a coalition for health AI, now over 2 ,400 institutions to try and create those regulations. But I'll tell you this, Mayo Clinic has 159 AI algorithms that run the practice every day.
I would push back strongly if my physician did not use those algorithms to provide care to me. There is no doubt those algorithms plus physicians plus providers will give you much better care than you have now. And therefore, the tipping point has happened. Now we need to scale it. To scale it, we need regulation. We need regulation because perversely, healthcare, as you said, is very conservative, right? So in the absence of regulation, most healthcare institutions won't move.
So we need regulation. We just need to make sure we're not regulating the past, we're regulating towards the future. You need trust. Healthcare is built on trust. There's very little trust in AI. I mean, very little, right? And that's why healthcare needs to step up, publish much more, be much more active at creating better solutions. But the potential is immense. At the moment, all we're doing, all being relative, is taking something we already know how to do and make it better.
Very soon, we'll be doing things that were just simply impossible to do in healthcare. And we need to plan for that, and we need to build
the infrastructure to be able to do that. So Gianrico, you and I have talked a lot about Mayo's innovation with Hospital at Home. Last year, you launched the Cancer Care Beyond Walls, which administers intravenous chemotherapy at home rather than requiring hospitalization. So how far do you see we can push digital and remote care options? And is there a limit to what can be done outside the home? And how are they going to change the nature of what actually happens
inside hospitals? Yeah. So the answer is, it's going to go so much further than we think is possible, yet it's not going to go where some dreamers are thinking it's going. That's sort of my first thing. So first things first, Mayo Clinic has a primary value. The needs of the patient come first. Anybody who's given a diagnosis of a cancer, a serious cancer diagnosis to a patient knows that that's only the first thing. The indignities of having to deal with taking time off work to travel to an infusion center, finding a family member or friend to drive you and back made us decide that we would try and make it such that we try and drive our own infusion centers
out of business. And the way we did that is we created Cancer Care Beyond Walls, where we created on a platform the ability for any company to work with us to deliver safely intravenous therapy at home and up to now early days but we've shown that it is at least equivalent to being an infusion center from a safety standpoint. The reason we're able to do it is because we've platformized everything we do and it's always built on the other thing which is advanced care at home which is can you take the admissions that should be in the hospital and safely treat them at home and over the last three years we found that we can do that at 80 %
of the cost of a hospital admission, a 50 % reduction in readmission rates compared to comparable people who are admitted to the hospital and greater patient and family satisfaction. But it has to be a platform because you need somebody that is providing the backup system so that you have reliable Wi-Fi. You need to have people that can go in and get laundry when it's covered in blood. You need people to go in and deliver medications.
So we have an agreement with our drone companies to be able to do that. So there is so much more we can do. And what we'll be seeing is what is traditionally inpatient becomes outpatient. What is traditionally outpatient can go in a home. Or what is traditionally primary care becomes available in stores and in kits. What people, however, forget is that we're humans. We get old and we get sick. And as technology improves, we will get older, we will get sicker, and we'll get some really sick to a point where we can do some remarkable things to at least improve your healthy lifespan, and that's going to require hospitals.
So this thing about hospitals going away makes no sense at all to me. What's going to happen is that the hospital has to be totally different. It has to be a place where, in everything I've said, seamlessly flows, where digital care, which requires actually a physical infrastructure to deliver, can happen so that you don't choose. It just happens to you as you go along, where the walls of the hospital really function as a caregiver, because they're able to detect how well you slept, they'll detect your vital signs, they can help us, tell us something about you.
For that to happen is what you mentioned. We're at 7 billion at the moment. We'll probably put another 2 billion soon in Arizona to completely reimagine how you do this infrastructure. The size of each individual room will change, but also the way we look at it. At the moment, we still have platforms where all the OR rooms, operating rooms are at one level. All the radiology is another level, and you have to break that paradigm.
Can you tell us a little bit about what's happening in healthcare overall? Look out over the horizon. What can we expect over the period of the next 10 years? What are some of the dazzling things that are likely to happen? and what's happening in particular in Mayo to enable that?
So, globally, we are at this fork, right? Are we going to continue to innovate on top of a model that is no longer scalable and affordable, or are we going to invest in infrastructure to be able to take a different path? Every country is going to have to make that decision. Some countries are making it, and are making it in different ways. We're proud of the fact that there are entire countries that are probably joining our platform in the next year that are taking that leap.
From a Mayo standpoint, here's what you see us do. One is there's no reason why you cannot cure osteoarthritis. There's just no reason. It's a disease. We always take it for it. It's a disease of aging. Everybody's going to get it. No, there are molecular pathways that happen. So you will see much more of that. For that to diffuse, we need, and I keep coming back to it because I'm convinced of it, is that we truly need better platforms.
And so what you'll see Mayo do is continue to invest significantly into our platform architecture. And what you will see us do is take the approach that what comes out of it will do several things with it. One, we'll make ourselves better because we need to remain in the category of one. We owe it to our past and present and future patients. Number two, we will allow others to use it for free. Number three, we'll work with companies who want to work with us to create products that will have benefit, but also have revenue that we can put into our mission.
And that number four, we will continue to build an infrastructure that's strong enough to be able to be used throughout the world. So that's what we'll do on the platform. From an AI standpoint, we will continue to move beyond algorithms to create end-to-end solutions. There's nothing more frustrating for a provider to, in front of a patient, get something that is divorced from the patient and everything that provider knows about the patient. So the first algorithm was great.
The fifth algorithm is a nuisance for a provider. And so you need to really create end-to-end solutions and then you need to embed them directly into the practice and so that's where you see us going one of the first things we also did was we created a product called validate and validate allows anybody to get their own algorithm put it onto our platform and then figure out how it performs and what we're finding out is that some algorithms that are really good sears a company that had an epilepsy algorithm performed really great but there was one section of the population where it didn't do as well and they were able to go back change that and get fda
approval so those are the first two. Number three is we'll push hard on some of the technologies you said. Biotherapeutics. Without a doubt, biotherapeutics will grow tremendously. Teragnostics, I mentioned, the combination of diagnosis and therapy. We will push hard in 2026 to bring to North America for the first time carbon therapy. So at the moment in cancer, we have radiation therapy. It could be either standard or proton, but 11 % of all cancers are radio resistant, including some of the sarcomas that affect kids.
We think there's a big opportunity to use carbon, which is much heavier and carbon can get after those radio resistant tumors so we'll invest in the first facility in north america to do that and we think when you destroy dna that way you create so many neoantigens that then you have an opportunity to create vaccines that will combine with those so
you'll see us go in that route so i've got a final question but you've got 80,000 employees and you're expanding pretty uh dramatically what about the human resource constraints are you sanguine about the ability to recruit and train and motivate the workforce that's necessary to
realize this vision. What's happened to us in healthcare is that the burden has become such, it's become very unattractive to enter healthcare. For some obvious reasons, it's tough. Looking after sick people is hard. But the second thing that's happened, as societies, we become much less respectful of each other, and we're seeing it in our hospitals. So part of the give and take for a healthcare worker is you're going to work really hard and patients and families are going to embrace you and thank you.
I'm not saying, you know, it's part of, but that's what has happened. And you go home feeling good, very tired, but good. At the moment, violence and work has increased. Families are assaulting healthcare workers. And the response has been to institutionalize the interaction between, in the emergency department, between people who are sick and the people on the other end, which I think is a mistake. We're going to have to figure out a much better way of doing it.
But that is a burden. And then the third burden is that healthcare wages have increased more than non-healthcare wages, but there are some areas where now the gap between doing something in another field and in healthcare is not big enough that you are no longer willing to put up with some of the things, the shift work. So for that to change, what we're pushing for is much shorter training, much shorter training intervals. It used to take us 18 months to train an MR technician using AI, using virtual education.
We're doing it in eight months. And what people expect is that they have a career ladder from day one. It used to be in healthcare. Work hard. You get the next promotion. You get the promotion. Now people expect you, as soon as you get hired, to know what your next step is. So we're responding to that. And we do believe that if you tell everybody that their job is safe, it may not be the same job, but their job is safe, that you can bring back some of the positivity and interactions with patients and the feeling that is indescribable when you have a successful therapy for somebody.
And if you start focusing more on that, and that's what we're doing, and a little less on walls and microphones and things to keep people safe, I do believe that in the next three years, we're going to see a switchback where healthcare as a profession is going to find a little bit more of a better footing.
Well, Gianrico, let me tell you, you have dazzled and convinced us. Ladies and gentlemen, what you see here in Gianrico Farrugia, I think, is someone not only who has the extraordinary capability, but who has the intense commitment and really compassion that makes him, as the leader of Mayo, the most hopeful sign, perhaps, of this whole retreat thus far. So thank you, Gianrico, for a round.
This podcast is produced by the Global Business Policy Council, a specialised think tank within the global management consulting firm, Kearney. For the past 30 years, the Council has been a strategic service for the world's top executives, government officials and business-minded thought leaders. The Council is dedicated to helping CEOs and government leaders anticipate the plan for the future, Learn more about the Global Business Policy Council at kearney.com forward slash GBPC.